Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.47 USD
Change Today -0.07 / -1.07%
Volume 504.5K
OSUR On Other Exchanges
As of 5:20 PM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald H. Spair

Chief Operating Officer, Chief Financial Officer and Director, OraSure Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Ronald H. Spair, also known as Ron, has been the Chief Financial Officer of OraSure Technologies, Inc. since November 2001 and its Chief Operating Officer since October 5, 2006. Mr. Spair served as Executive Vice President of OraSure Technologies, Inc. from November 2001 to October 2006 and served as its Head of Investor. He served as Chief Financial Officer, Vice President and Secretary of Delsys Pharmaceutical Corporation from January 2001 to September 2001. Prior ...

Read Full Background

Corporate Headquarters*

220 East First Street
Bethlehem, Pennsylvania 18015

United States

Phone: 610-882-1820
Fax: 610-882-1830

Board Members Memberships*

Chief Operating Officer, Chief Financial Officer and Director


Rider University
Rider University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$442,450

Stock Options*

Restricted Stock Awards$240,798
All Other Compensation$4,000
Exercisable Options483,932
Exercisable Options Value$172,974
Unexercisable Options202,950
Unexercisable Options Value$1,899
Total Value of Options$174,872
Total Number of Options686,882

Total Compensation*

Total Annual Cash Compensation$709,840
Total Short Term Compensation$442,450
Other Long Term Compensation$244,798
Total Calculated Compensation$1,311,729
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $6.47 USD -0.07


Paul Averback M.D., DABPFounder, Chairman, Chief Executive Officer, President and Member of Communications Committee
Nymox Pharmaceutical Corporation
Ronan O’Caoimh Co-Founder, Chairman, Chief Executive Officer and Chairman of Compensation Committee
Trinity Biotech plc
John J. Sperzel III, B.Sc.Chief Executive Officer, President and Director
Chembio Diagnostics, Inc.
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at